BUZZ-Biocytogen hits record high on green light of Shanghai listing plan

Reuters
09/25
BUZZ-Biocytogen hits record high on green light of Shanghai listing plan

** Shares of Biocytogen Pharmaceuticals (Beijing) 2315.HK jump 9.6% to HK$30.58, their highest level since debut in September 2022, and on course for a second session of gains

** Stock set for the biggest one-day pct gain since September 18

** The China-based drug developer said on Wednesday the listing committee for the Sci-Tech Board of the Shanghai Stock Exchange has approved the company's plan to issue and listing of its A shares on the Sci-Tech Board in Shanghai

** YTD, stock up 258.6%, Hang Seng Biotech Index .HSBIO up 100.7%

(Reporting by Donny Kwok)

((donny.kwok@thomsonreuters.com))

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10